- Home
- KOSS vs ATRA Comparison
KOSS vs ATRA Comparison
Compare KOSS & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOSS
- ATRA
- Stock Information
- Founded
- KOSS 1953
- ATRA 2012
- Country
- KOSS United States
- ATRA United States
- Employees
- KOSS N/A
- ATRA N/A
- Industry
- KOSS Consumer Electronics/Appliances
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KOSS Consumer Staples
- ATRA Health Care
- Exchange
- KOSS Nasdaq
- ATRA Nasdaq
- Market Cap
- KOSS 63.0M
- ATRA 43.4M
- IPO Year
- KOSS N/A
- ATRA 2014
- Fundamental
- Price
- KOSS $7.60
- ATRA $9.05
- Analyst Decision
- KOSS
- ATRA Hold
- Analyst Count
- KOSS 0
- ATRA 6
- Target Price
- KOSS N/A
- ATRA $24.88
- AVG Volume (30 Days)
- KOSS 234.4K
- ATRA 86.9K
- Earning Date
- KOSS 11-01-2024
- ATRA 10-30-2024
- Dividend Yield
- KOSS N/A
- ATRA N/A
- EPS Growth
- KOSS N/A
- ATRA N/A
- EPS
- KOSS N/A
- ATRA N/A
- Revenue
- KOSS $12,265,069.00
- ATRA $62,387,000.00
- Revenue This Year
- KOSS N/A
- ATRA $1,190.80
- Revenue Next Year
- KOSS N/A
- ATRA N/A
- P/E Ratio
- KOSS N/A
- ATRA N/A
- Revenue Growth
- KOSS N/A
- ATRA 809.03
- 52 Week Low
- KOSS $2.27
- ATRA $4.98
- 52 Week High
- KOSS $18.73
- ATRA $39.50
- Technical
- Relative Strength Index (RSI)
- KOSS 55.73
- ATRA 59.48
- Support Level
- KOSS $6.88
- ATRA $8.68
- Resistance Level
- KOSS $8.50
- ATRA $10.05
- Average True Range (ATR)
- KOSS 0.38
- ATRA 0.52
- MACD
- KOSS 0.11
- ATRA 0.17
- Stochastic Oscillator
- KOSS 57.65
- ATRA 64.91
About KOSS Koss Corporation
Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-cancelling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).